Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: The clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness

Cancer

Volumn 83, Issue 7, 1998, Pages 1300-1306

  Kuniyasu, Tetsuya ^a   Nakamura, Takeshi ^a   Tabuchi, Yoshiki ^a   Kuroda, Yoshikazu ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Gastric carcinoma; Immunohistochemical quantitation; Survival; Thymidylate synthase

Indexed keywords

FLUOROURACIL; MITOMYCIN C; POLYCLONAL ANTIBODY; THYMIDYLATE SYNTHASE; UFT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PERITONEUM METASTASIS; PRIORITY JOURNAL; STOMACH CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SIGNET RING CELL; DRUG RESISTANCE; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; THYMIDYLATE SYNTHASE;

EID: 0032189399     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981001)83:7<1300::AID-CNCR5>3.0.CO;2-M     Document Type: Article

References (28)

1. Pinedo HM, Peters GJ. 5-Fluorouracil: biochemistry and pharmacology. J Clin Oncol 1988;6:1653-64.
2. Santi DV, Danenberg PV. Folates in pyrimidine nucleoside biosynthesis. In: Blankey RL, Benkovic SJ, editors. Folates and pteridines. New York: Wiley-Liss, Inc., 1984;345-98.
3. Heidelberger C. Fluorinated pyrimidines and their nucleosides. In: Sartorelli AC, Johns DG, editors. Handbook of experimental pharmacology. New York: Springer-Verlag, 1975;38:193-231.
4. Washtein WL. Increased levels of thymidylate synthase in cells exposed to 5-fluorouracil. Mol Pharmacol 1984;25: 171-7.
5. Berger SH, Chung-Her J, Johnson LF, Berger FG. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells. Mol Pharmacol 1987;28:461-7.
6. Clark JK, Berger SL, Mittelman A, Berger FG. Thymidylate synthase gene amplification in a colon tumor resistant to fluoropyrimidine chemotherapy. Cancer Treat Rep 1987;71: 261-5.
7. Johnston PG, Drake JC, Trepel J, Allegra CJ. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil sensitive and resistant human cancer cell lines. Cancer Res 1992;52:4306-12.
8. Cunningham D, Zalcberg JR, Rath U. "Tumudex" (ZD1694): results of a randomized trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leukopenia. Eur J Cancer 1995;31:1945-54.
9. Seitz JF, Cunnungham D, Rath U. Final results and survival data of a large randomized trial of "Tomudex" in advanced colorectal cancer (ACC) confirm comparable efficacy to 5-fluorouracil plus leucovorin (5-FU+LV). Proc Am Soc Clin Oncol 1996;15:201.
10. Jackman AL, Taylor GA, Gibson W. ICID1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res 1991;51: 5579-86.
11. Jackman AL, Farrugia DC, Gibson W. ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer. Eur J Cancer 1995;31:1277-82.
12. Rustum YM, Harstrick A, Cao S. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J Clin Oncol 1997;15:389-400.
13. Johnston PG, Lenz HJ, Leichman CG. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 1995;55:1407-12.
14. Lenz HJ, Leichman CG, Danenberg KD. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol 1995;14:176-82.
15. Leichman L, Lenz HJ, Leichman CG. Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. Eur J Cancer 1995;31:1306-10.
16. Yamachika T, Nakanishi H, Inada K, Tsukamoto T, Kato T, Fukushima M, et al. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer 1998;82:70-7.
17. Johnston PG, Liang CM, Henry S. Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res 1991;51:6668-76.
18. Okabe K, Tsujimoto H, Fukushima M. Preparation of the antibodies against recombinant human thymidylate synthase for the detection of its intratumoral levels and the application to sensitivity-study of 5-fluorouracil. Oncol Rep 1997;4:685-90.
19. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. 1st English edition. Tokyo: Kanehara & Co., Ltd.
20. Shi SR, Iman A, Young L. Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J Histochem Cytochem 1991;43:193.
21. Shin RW, Iwaki T, Kitamoto T. Hydrated autoclave pretreatment enhances the immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab Invest 1991; 64:693-702.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
23. Cox DR. Regression models and life tables. J R Stat Soc 1972;B34:187-220.
24. Johnstin PG, Fisher ER, Rockette HE, The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 1994;12:2640-7.
25. Peters GJ, van der Wilt CL, van Groeningen CJ. Thymidylate synthase inhibition after administration of fluorouracil with and without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J Clin Oncol 1994;12: 2035-42.
26. Peters GJ, van der Wilt CL, van Triest B. Thymidylate synthase and drug resistance. Eur J Cancer 1995;31A:1299-305.
27. Hall PA, Levison DA, Woods AL. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-92.
28. Nakamura T, Tabuchi Y, Nakae S, Ohno M, Saitoh Y. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Cancer 1996;77:1741-6.